SCHEMBL5295702

SCHEMBL5295702

O=C(CSc1ccc(O)cc1)NCCCCCC(=O)Nc1cccc(-c2ccccc2)c1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 16/20 0.58
HDAC1 Q13547 16/20 0.58
HDAC3 O15379 14/20 0.57
HDAC4 P56524 13/20 0.57
HDAC7 Q8WUI4 13/20 0.57
HDAC2 Q92769 13/20 0.57
HDAC10 Q969S8 13/20 0.57
HDAC11 Q96DB2 13/20 0.57
HDAC8 Q9BY41 13/20 0.57
HDAC9 Q9UKV0 13/20 0.57
HDAC5 Q9UQL6 13/20 0.57
MAPK1 P28482 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HSD17B10 Q99714 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
POLB P06746 1/20 0.46
MEN1 O00255 1/20 0.46
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5279352 0.94 HDAC6 (0.62) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5283939 0.91 HDAC6 (0.60) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5293181 0.91 HDAC6 (0.57) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5286647 0.91 HDAC6 (0.57) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5278693 0.91 HDAC6 (0.58) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5284679 0.91 HDAC6 (0.57) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL6038080 0.90 HDAC6 (0.56) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5277766 0.89 HDAC6 (0.57) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5283740 0.86 HDAC1 (0.58) HDAC6HDAC1HDAC3HDAC4HDAC7
SCHEMBL5285806 0.84 HDAC6 (0.64) HDAC6HDAC1HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1863804-A1 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2007-12-12 EP claimed
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US claimed
WO-2006102760-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2006-10-05 WO claimed
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264415-A1 Inhibitors of histone deacetylase HDAC1, HDAC3, HDAC11 HDAC6 17/4885HDAC1 1/4885HDAC3 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.